Tanespimycina

Tanespimycina Uses, Dosage, Side Effects, Food Interaction and all others data.

Tanespimycina, manufactured by Conforma Therapeutics is under development as a small molecule inhibitor of heat shock protein 90 (HSP90). It is developed for the treatment of several types of cancer, solid tumors or chronic myelogenous leukemia.

Table Of contents

• Tanespimycina
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Tanespimycina
Generic	Tanespimycin
Tanespimycin Other Names	17AAG, Tanespimycin, tanespimycina
Type
Formula	C31H43N3O8
Weight	Average: 585.698 Monoisotopic: 585.305015357
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in leukemia (myeloid) and solid tumors.

How Tanespimycina works

Tanespimycina is a small molecule inhibitor of heat shock protein 90 (HSP90). HSP90 is a molecular “chaperone” protein that controls protein shape or conformation, including that of key signaling molecules involved in the growth and survival of tumor cells.

Innovators Monograph

You find simplified version here Tanespimycina